Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1973-04-20
1978-10-24
Hines, Robert V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2605011, 260563P, 424316, A01N 920, A01N 924
Patent
active
041221931
ABSTRACT:
Certain 1,3,5-trisubstituted adamantane compounds having central nervous system activity, especially anti-Parkinsonism activity, method of preparing same, and pharmaceutical compositions thereof, method of influencing the central nervous system therewith.
REFERENCES:
patent: 3391142 (1968-07-01), Mills et al.
patent: 3789073 (1974-01-01), Narayama et al.
patent: 3929888 (1975-12-01), Cashin et al.
Eberhard et al., "Chemical Abstracts," vol. 71, p. 235, Section No. 38444b (1969).
Wagner et al., "Synthetic Organic Chemistry," p. 664 (1953).
Peteri Dezso
Scherm Arthur
Hines Robert V.
Hueschen Gordon W.
Merz & Co.
LandOfFree
Drugs or medicines for influencing the central nervous system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs or medicines for influencing the central nervous system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs or medicines for influencing the central nervous system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336630